The Patent Finder

Celtrix Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Celtrix Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Celtrix Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 6,040,292Methods for treating diabetes
Term ended
Term ended Jun 4, 2019 · From the USPTO record
Term endedTerm ended Jun 4, 2019From the USPTO record
US 6,417,330Insulin-like growth factor binding protein variants
Term ended
Term ended May 27, 2019 · From the USPTO record
Term endedTerm ended May 27, 2019From the USPTO record
US 6,436,897Pharmaceutical formulations for IGF/IGFBP
Term ended
Term ended Jun 1, 2018 · From the USPTO record
Term endedTerm ended Jun 1, 2018From the USPTO record
US 6,514,937Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
Term ended
Term ended Feb 25, 2017 · From the USPTO record
Term endedTerm ended Feb 25, 2017From the USPTO record
US 6,518,238Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
Term ended
Term ended Feb 25, 2017 · From the USPTO record
Term endedTerm ended Feb 25, 2017From the USPTO record
US 6,124,259Method for treating ophthalmic disorders with IGFBP
Lapsed on the fee record
Ended Sep 26, 2012 · From the USPTO record
Lapsed on the fee recordEnded Sep 26, 2012From the USPTO record
US 6,025,332Method for treating low circulating levels of sex hormone steroids associated with aging using IGF or IGF/IGFBP-3
Lapsed on the fee record
Ended Feb 15, 2012 · From the USPTO record
Lapsed on the fee recordEnded Feb 15, 2012From the USPTO record
US 6,025,368Method for treating the symptoms of chronic stress-related disorders using IGF
Lapsed on the fee record
Ended Feb 15, 2012 · From the USPTO record
Lapsed on the fee recordEnded Feb 15, 2012From the USPTO record
US 6,685,930Methods and substances for recruiting therapeutic agents to solid tumors
Formerly held
Lapsed on the fee record
Ended Feb 3, 2012 · From the USPTO record
Lapsed on the fee recordEnded Feb 3, 2012From the USPTO record
US 6,017,885IGF/IGFBP complex for promoting bone formation and for regulating bone remodeling
Lapsed on the fee record
Ended Jan 25, 2012 · From the USPTO record
Lapsed on the fee recordEnded Jan 25, 2012From the USPTO record
10 of 63 patents shown.
Pro members see all 63.
Pro members: see all 63 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited